ASX - By Stock
|
OBL |
Re:
Ann: Becoming a substantial holder
|
|
lexcorp
|
15 |
5.2K |
0 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
15
|
5.2K
|
0
|
|
ASX - By Stock
|
OBL |
Re:
Ann: Becoming a substantial holder
|
|
lexcorp
|
15 |
5.2K |
0 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
15
|
5.2K
|
0
|
|
ASX - By Stock
|
LLL |
Re:
Ann: Sole Funding Arrangement for Goulamina Executed with Ganfeng
|
|
lexcorp
|
19 |
8.3K |
0 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
19
|
8.3K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: AGM Chairman and CEO Presentation
|
|
lexcorp
|
42 |
13K |
1 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
42
|
13K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: AGM Chairman and CEO Presentation
|
|
lexcorp
|
42 |
13K |
4 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
42
|
13K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: AGM Chairman and CEO Presentation
|
|
lexcorp
|
42 |
13K |
2 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
42
|
13K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: AGM Chairman and CEO Presentation
|
|
lexcorp
|
42 |
13K |
1 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
42
|
13K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Notice of Annual General Meeting - Withdrawal of Resolution
|
|
lexcorp
|
6 |
1.7K |
0 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
6
|
1.7K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
AGM 2024 questions - please submit here.
|
|
lexcorp
|
93 |
27K |
1 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
93
|
27K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
AGM 2024 questions - please submit here.
|
|
lexcorp
|
93 |
27K |
6 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
93
|
27K
|
6
|
|
ASX - By Stock
|
OBL |
Re:
Ann: Becoming a substantial holder
|
|
lexcorp
|
15 |
5.2K |
0 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
15
|
5.2K
|
0
|
|
ASX - By Stock
|
OBL |
Re:
Ann: Becoming a substantial holder
|
|
lexcorp
|
15 |
5.2K |
0 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
15
|
5.2K
|
0
|
|
ASX - By Stock
|
OBL |
Re:
Ann: Becoming a substantial holder
|
|
lexcorp
|
15 |
5.2K |
1 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
15
|
5.2K
|
1
|
|
ASX - By Stock
|
OBL |
Re:
Ann: Becoming a substantial holder
|
|
lexcorp
|
15 |
5.2K |
0 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
15
|
5.2K
|
0
|
|
ASX - By Stock
|
APE |
Re:
Ann: AGM Material including Market Guidance
|
|
lexcorp
|
39 |
11K |
3 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
39
|
11K
|
3
|
|
ASX - By Stock
|
APE |
Re:
Ann: Change of Director's Interest Notice - POLITIS
|
|
lexcorp
|
4 |
995 |
5 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
4
|
995
|
5
|
|
ASX - By Stock
|
APE |
Re:
Ann: AGM Material including Market Guidance
|
|
lexcorp
|
39 |
11K |
3 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
39
|
11K
|
3
|
|
ASX - By Stock
|
OBL |
Re:
Ann: CBA Class Action Judgment
|
|
lexcorp
|
22 |
11K |
1 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
22
|
11K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
AGM 2024 questions - please submit here.
|
|
lexcorp
|
93 |
27K |
2 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
93
|
27K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
AGM 2024 questions - please submit here.
|
|
lexcorp
|
93 |
27K |
6 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
93
|
27K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
AGM 2024 questions - please submit here.
|
|
lexcorp
|
93 |
27K |
1 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
93
|
27K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
First VIV in Europe! Great outcome.
|
|
lexcorp
|
35 |
10K |
3 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
35
|
10K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
First VIV in Europe! Great outcome.
|
|
lexcorp
|
35 |
10K |
0 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
35
|
10K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
AGM 2024 questions - please submit here.
|
|
lexcorp
|
93 |
27K |
7 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
93
|
27K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
PCR Europe presentation
|
|
lexcorp
|
35 |
7.8K |
4 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
35
|
7.8K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
PCR Europe presentation
|
|
lexcorp
|
35 |
7.8K |
1 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
35
|
7.8K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
PCR Europe presentation
|
|
lexcorp
|
35 |
7.8K |
2 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
35
|
7.8K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
PCR Europe presentation
|
|
lexcorp
|
35 |
7.8K |
4 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
35
|
7.8K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
PCR Europe presentation
|
|
lexcorp
|
35 |
7.8K |
13 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
35
|
7.8K
|
13
|
|
ASX - By Stock
|
AVR |
Re:
PCR Europe presentation
|
|
lexcorp
|
35 |
7.8K |
2 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
35
|
7.8K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
PCR Europe presentation
|
|
lexcorp
|
35 |
7.8K |
5 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
35
|
7.8K
|
5
|
|
ASX - By Stock
|
FMG |
Re:
Alta Copper
|
|
lexcorp
|
3 |
2.0K |
3 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
3
|
2.0K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
lexcorp
|
239 |
58K |
0 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
239
|
58K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
AGM 2024 questions - please submit here.
|
|
lexcorp
|
93 |
27K |
13 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
93
|
27K
|
13
|
|
ASX - By Stock
|
OBL |
Re:
Ann: CBA Class Action Judgment
|
|
lexcorp
|
22 |
11K |
2 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
22
|
11K
|
2
|
|
ASX - By Stock
|
FFX |
Re:
Ann: Settlement with Govt of Mali & Agreement with Leo & Ganfeng
|
|
lexcorp
|
128 |
47K |
5 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
128
|
47K
|
5
|
|
ASX - By Stock
|
OBL |
Re:
Ann: Change in substantial holding from PPT
|
|
lexcorp
|
17 |
6.7K |
0 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
17
|
6.7K
|
0
|
|
ASX - By Stock
|
OBL |
Re:
Ann: Change in substantial holding from PPT
|
|
lexcorp
|
17 |
6.7K |
0 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
17
|
6.7K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Published paper that mentions DurAVR
|
|
lexcorp
|
14 |
5.2K |
3 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
14
|
5.2K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
lexcorp
|
43 |
12K |
1 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
43
|
12K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
lexcorp
|
43 |
12K |
8 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
43
|
12K
|
8
|
|
Humour
|
|
Re:
Over 45?
|
|
lexcorp
|
9 |
3.4K |
0 |
11/04/24 |
11/04/24 |
Humour
|
9
|
3.4K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: First Austria-based treatments utilising the OncoSil device
|
|
lexcorp
|
40 |
10K |
2 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
40
|
10K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: First Austria-based treatments utilising the OncoSil device
|
|
lexcorp
|
40 |
10K |
2 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
40
|
10K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: First Austria-based treatments utilising the OncoSil device
|
|
lexcorp
|
40 |
10K |
3 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
40
|
10K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Placement and Entitlement Offer to raise up to $7.1 million
|
|
lexcorp
|
118 |
33K |
1 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
118
|
33K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore secures Singapore and Vietnam market approvals
|
|
lexcorp
|
49 |
21K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
49
|
21K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
AVR results presentation at CRT 24 Washington DC 9th to 12th March
|
|
lexcorp
|
65 |
24K |
2 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
65
|
24K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
AVR results presentation at CRT 24 Washington DC 9th to 12th March
|
|
lexcorp
|
65 |
24K |
3 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
65
|
24K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Symposium
|
|
lexcorp
|
20 |
7.4K |
0 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
20
|
7.4K
|
0
|
|